Emtricitabine/TDF

CHEBI:CHEBI_754394

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_name
TENOFOVIR DISOPROXIL FUMARATE
rxcui
476556
product_type
HUMAN PRESCRIPTION DRUG
route
ORAL
marketing_category
ANDA
listing_expiration_date
20241231
dosage_form
TABLET, FILM COATED
active_ingredient_strength
300 mg/1
labeler_name
Direct_Rx
manufacturer_name
Direct_Rx
unii
OTT9J7900I
nui
N0000009947
pharm_class_epc
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
pharm_class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
pharm_class_moa
Nucleoside Reverse Transcriptase Inhibitors [MoA]
pharm_class_cs
Nucleosides [CS]
marketing_start_date
20221205
package_marketing_start_date
20221205
application_number
ANDA090513
generic_name
Emtricitabine/TDF
brand_name
Emtricitabine/TDF
brand_name_base
Emtricitabine/TDF
product_ndc
72189-403
spl_id
f63e9477-8015-070b-e053-2a95a90a0d5f
package_ndc
72189-403-03
package_description
3 TABLET, FILM COATED in 1 BOTTLE (72189-403-03)
spl_set_id
ef1a90ca-92bc-3787-e053-2a95a90a58ec
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class